Clinical trial
Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma
NCT00003008 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003008 |
|---|---|
| Title | Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma |
| Official title | Pilot Study to Evaluate the Potential Interactions Between Paclitaxel and Protease Inhibitors in Patients With AIDS-Related Kaposi's Sarcoma |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH AIDS Associated Malignancies Clinical Trials Consortium |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | indinavir sulfate, nelfinavir mesylate, paclitaxel, ritonavir, saquinavir mesylate |
| Enrollment | 33 |
| Start date | Dec 15, 1997 |
| Primary completion | Jun 1, 2006 |
| First posted | Jul 11, 2003 |
| Last update posted | Jun 15, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: